140 related articles for article (PubMed ID: 25724892)
1. Role of Proteus mirabilis MR/P fimbriae and flagella in adhesion, cytotoxicity and genotoxicity induction in T24 and Vero cells.
Scavone P; Villar S; Umpiérrez A; Zunino P
Pathog Dis; 2015 Jun; 73(4):. PubMed ID: 25724892
[TBL] [Abstract][Full Text] [Related]
2. Proteus mirabilis uroepithelial cell adhesin (UCA) fimbria plays a role in the colonization of the urinary tract.
Pellegrino R; Scavone P; Umpiérrez A; Maskell DJ; Zunino P
Pathog Dis; 2013 Mar; 67(2):104-7. PubMed ID: 23620155
[TBL] [Abstract][Full Text] [Related]
3. Mannose-resistant Proteus-like and P. mirabilis fimbriae have specific and additive roles in P. mirabilis urinary tract infections.
Zunino P; Sosa V; Schlapp G; Allen AG; Preston A; Maskell DJ
FEMS Immunol Med Microbiol; 2007 Oct; 51(1):125-33. PubMed ID: 17854474
[TBL] [Abstract][Full Text] [Related]
4. Aggregative adherence of uropathogenic Proteus mirabilis to cultured epithelial cells.
Rocha SP; Elias WP; Cianciarullo AM; Menezes MA; Nara JM; Piazza RM; Silva MR; Moreira CG; Pelayo JS
FEMS Immunol Med Microbiol; 2007 Nov; 51(2):319-26. PubMed ID: 17714491
[TBL] [Abstract][Full Text] [Related]
5. New aspects of RpoE in uropathogenic Proteus mirabilis.
Liu MC; Kuo KT; Chien HF; Tsai YL; Liaw SJ
Infect Immun; 2015 Mar; 83(3):966-77. PubMed ID: 25547796
[TBL] [Abstract][Full Text] [Related]
6. Mannose-resistant Proteus-like fimbriae are produced by most Proteus mirabilis strains infecting the urinary tract, dictate the in vivo localization of bacteria, and contribute to biofilm formation.
Jansen AM; Lockatell V; Johnson DE; Mobley HL
Infect Immun; 2004 Dec; 72(12):7294-305. PubMed ID: 15557655
[TBL] [Abstract][Full Text] [Related]
7. New aspects of the role of MR/P fimbriae in Proteus mirabilis urinary tract infection.
Zunino P; Geymonat L; Allen AG; Preston A; Sosa V; Maskell DJ
FEMS Immunol Med Microbiol; 2001 Aug; 31(2):113-20. PubMed ID: 11549418
[TBL] [Abstract][Full Text] [Related]
8. Involvement of polyphosphate kinase in virulence and stress tolerance of uropathogenic Proteus mirabilis.
Peng L; Jiang Q; Pan JY; Deng C; Yu JY; Wu XM; Huang SH; Deng XY
Med Microbiol Immunol; 2016 Apr; 205(2):97-109. PubMed ID: 26233310
[TBL] [Abstract][Full Text] [Related]
9. Identification of MrpI as the sole recombinase that regulates the phase variation of MR/P fimbria, a bladder colonization factor of uropathogenic Proteus mirabilis.
Li X; Lockatell CV; Johnson DE; Mobley HL
Mol Microbiol; 2002 Aug; 45(3):865-74. PubMed ID: 12139630
[TBL] [Abstract][Full Text] [Related]
10. Repression of bacterial motility by a novel fimbrial gene product.
Li X; Rasko DA; Lockatell CV; Johnson DE; Mobley HL
EMBO J; 2001 Sep; 20(17):4854-62. PubMed ID: 11532949
[TBL] [Abstract][Full Text] [Related]
11. Requirement of MrpH for mannose-resistant Proteus-like fimbria-mediated hemagglutination by Proteus mirabilis.
Li X; Johnson DE; Mobley HL
Infect Immun; 1999 Jun; 67(6):2822-33. PubMed ID: 10338487
[TBL] [Abstract][Full Text] [Related]
12. MrpJ Directly Regulates Proteus mirabilis Virulence Factors, Including Fimbriae and Type VI Secretion, during Urinary Tract Infection.
Debnath I; Stringer AM; Smith SN; Bae E; Mobley HLT; Wade JT; Pearson MM
Infect Immun; 2018 Oct; 86(10):. PubMed ID: 30082479
[No Abstract] [Full Text] [Related]
13. Proteus mirabilis flagella and MR/P fimbriae: isolation, purification, N-terminal analysis, and serum antibody response following experimental urinary tract infection.
Bahrani FK; Johnson DE; Robbins D; Mobley HL
Infect Immun; 1991 Oct; 59(10):3574-80. PubMed ID: 1680106
[TBL] [Abstract][Full Text] [Related]
14. Fimbriae of uropathogenic Proteus mirabilis.
Rocha SP; Pelayo JS; Elias WP
FEMS Immunol Med Microbiol; 2007 Oct; 51(1):1-7. PubMed ID: 17640292
[TBL] [Abstract][Full Text] [Related]
15. Flagellate and non-flagellate Proteus mirabilis in the development of experimental urinary tract infection.
Zunino P; Piccini C; Legnani-Fajardo C
Microb Pathog; 1994 May; 16(5):379-85. PubMed ID: 7815921
[TBL] [Abstract][Full Text] [Related]
16. Fimbriae have distinguishable roles in Proteus mirabilis biofilm formation.
Scavone P; Iribarnegaray V; Caetano AL; Schlapp G; Härtel S; Zunino P
Pathog Dis; 2016 Jul; 74(5):. PubMed ID: 27091004
[TBL] [Abstract][Full Text] [Related]
17. cAMP receptor protein regulates mouse colonization, motility, fimbria-mediated adhesion, and stress tolerance in uropathogenic Proteus mirabilis.
Tsai YL; Chien HF; Huang KT; Lin WY; Liaw SJ
Sci Rep; 2017 Aug; 7(1):7282. PubMed ID: 28779108
[TBL] [Abstract][Full Text] [Related]
18. Tissue-binding affinity of Proteus mirabilis fimbriae in the human urinary tract.
Sareneva T; Holthöfer H; Korhonen TK
Infect Immun; 1990 Oct; 58(10):3330-6. PubMed ID: 1976113
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of Proteus mirabilis structural fimbrial proteins as antigens against urinary tract infections.
Pellegrino R; Galvalisi U; Scavone P; Sosa V; Zunino P
FEMS Immunol Med Microbiol; 2003 May; 36(1-2):103-10. PubMed ID: 12727373
[TBL] [Abstract][Full Text] [Related]
20. Construction of an MR/P fimbrial mutant of Proteus mirabilis: role in virulence in a mouse model of ascending urinary tract infection.
Bahrani FK; Massad G; Lockatell CV; Johnson DE; Russell RG; Warren JW; Mobley HL
Infect Immun; 1994 Aug; 62(8):3363-71. PubMed ID: 7913698
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
